3-Amino-N-methyl-1H-1,2,4-triazole-5-carboxamide

Catalog No.: 
ACWTTA865
CAS No.: 
1019126-62-5
Molecular Formula: 
C4H7N5O
Molecular Weight: 
141.13
3-Amino-N-methyl-1H-1,2,4-triazole-5-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%
1g97%
5g97%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Amino-N-methyl-1H-1,2,4-triazole-5-carboxamide
IUPAC Name5-amino-N-methyl-4H-1,2,4-triazole-3-carboxamide
Molecular FormulaC4H7N5O
Molecular Weight141.13
SMILESO=C(C1=NC(N)=NN1)NC
InChI KeyAFLLHPQFSIEJFI-UHFFFAOYSA-N
Synonym3-amino-N-methyl-1H-1,2,4-triazole-5-carboxamide(SALTDATA: FREE);3-amino-N-methyl-1H-1,2,4-triazole-5-carboxamide(SALTDATA;5-Amino-N-methyl-1H-1,2,4-triazole-3-carboxamide;1H-1,2,4-Triazole-3-carboxamide, 5-amino-N-methyl-
CAS No.1019126-62-5

Synthetic Route by SureRoute

1. ACWTTA865 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJQBI136 route compound structure diagram
    ACJQBI1363641-14-3In Stock
  4. Then
  5. ACWTTA865 route product structure diagram
    ACWTTA8651019126-62-5
Inquiry

2. ACWTTA865 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJQBI136 route compound structure diagram
    ACJQBI1363641-14-3In Stock
  4. Then
  5. ACWTTA865 route product structure diagram
    ACWTTA8651019126-62-5
Inquiry

3. ACWTTA865 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACJQBI136 route compound structure diagram
    ACJQBI1363641-14-3In Stock
  6. Then
  7. ACWTTA865 route product structure diagram
    ACWTTA8651019126-62-5
Inquiry

Comments (0)